Skin Laboratory PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	165.55	176.73	229.13	271.8	282.12	197.55
Other Revenue	1.53	2.23	1.4	0.99	0.58	1.03
Revenue	167.08	178.96	230.53	272.8	282.7	198.57
Revenue Growth (YoY)	-22.82%	-22.37%	-15.49%	-3.50%	42.37%	17.80%
Cost of Revenue	47.37	49.53	57.5	63.23	70.65	65.56
Gross Profit	119.71	129.43	173.03	209.56	212.05	133.02
Selling, General & Admin	126.91	123.69	159.5	188.28	196.86	96.43
Operating Expenses	126.91	123.69	159.5	188.28	196.86	96.43
Operating Income	-7.2	5.74	13.53	21.28	15.19	36.59
Interest Expense	-0.13	-0.15	-0.25	-0.19	-0.18	-0.18
EBT Excluding Unusual Items	-7.33	5.59	13.28	21.1	15.01	36.41
Gain (Loss) on Sale of Investments	-	-	0.25	-0.07	-	-
Pretax Income	-7.33	5.59	13.53	21.02	15.01	36.41
Income Tax Expense	0.46	1.21	2.86	4.24	3.15	7.64
Net Income	-7.79	4.38	10.67	16.79	11.86	28.77
Net Income to Common	-7.79	4.38	10.67	16.79	11.86	28.77
Net Income Growth	-	-58.97%	-36.44%	41.59%	-58.80%	0.10%
Shares Outstanding (Basic)	124	113	43	2	2	2
Shares Outstanding (Diluted)	124	113	43	2	2	2
Shares Change (YoY)	83.28%	162.19%	2048.36%	-	-	-
EPS (Basic)	-0.06	0.04	0.25	8.39	5.93	14.39
EPS (Diluted)	-0.06	0.04	0.25	8.39	5.93	14.39
EPS Growth	-	-84.35%	-97.04%	41.59%	-58.80%	-
Free Cash Flow	-6.81	11.97	3.57	26.25	4.62	10.87
Free Cash Flow Per Share	-0.06	0.11	0.08	13.12	2.31	5.43
Dividend Per Share	-	-	27.580	7.500	8.000	6.830
Dividend Growth	-	-	267.73%	-6.25%	17.13%	1.19%
Gross Margin	71.65%	72.32%	75.06%	76.82%	75.01%	66.98%
Operating Margin	-4.31%	3.21%	5.87%	7.80%	5.37%	18.42%
Profit Margin	-4.66%	2.45%	4.63%	6.15%	4.19%	14.49%
Free Cash Flow Margin	-4.08%	6.69%	1.55%	9.62%	1.63%	5.47%
EBITDA	-6.73	6.2	14.43	21.62	15.61	37.03
EBITDA Margin	-4.03%	3.47%	6.26%	7.93%	5.52%	18.65%
D&A For EBITDA	0.47	0.46	0.9	0.34	0.42	0.44
EBIT	-7.2	5.74	13.53	21.28	15.19	36.59
EBIT Margin	-4.31%	3.21%	5.87%	7.80%	5.37%	18.42%
Effective Tax Rate	-	21.72%	21.16%	20.16%	20.99%	20.97%
Revenue as Reported	167.08	178.96	230.53	272.8	282.7	198.57
Advertising Expenses	-	89.63	123.68	150.16	-	48.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.